Home > Healthcare > Medical Devices > Therapeutic Devices > U.S. Dialysis Market

U.S. Dialysis Market Analysis

  • Report ID: GMI5091
  • Published Date: Sep 2024
  • Report Format: PDF

U.S. Dialysis Market Analysis

Based on type, the market is categorized into hemodialysis and peritoneal dialysis. The hemodialysis segment dominated the market with a revenue of around USD 25.4 billion in 2023.
 

  • Hemodialysis is more commonly used and widely available in dialysis centers across the country. It is the standard treatment for the majority of patients with ESRD, particularly those who may not be candidates for home-based therapies.
     
  • Additionally, many patients and physicians prefer hemodialysis due to the structured nature of the treatment, where care is provided by trained professionals in a clinical setting. This setup provides reassurance to patients, especially those who may be uncomfortable with or unable to manage the complexities of home-based treatments like peritoneal dialysis.
     

Based on product and services, the U.S. dialysis market is categorized into services, consumables, and equipment. The service segment dominated the market in 2023 with a market share of around 78.3%.
 

  • Dialysis is a lifelong, recurrent treatment for patients with ESRD. Patients typically undergo dialysis multiple times per week, leading to a continuous demand for dialysis services, which includes the use of dialysis centers, home dialysis programs, and associated healthcare services. This recurring need makes services the largest and most consistent revenue generator in the dialysis market.
     
  • Moreover, dialysis services encompass not only the procedure itself but also the comprehensive care provided to patients, including regular monitoring, management of treatment schedules, patient education, and emergency care. The extensive support system offered through dialysis services is essential for patient management, driving the dominance of this segment in the market.
     
U.S. Dialysis Market, By End-use (2023)

Based on end-use, the U.S. dialysis market is categorized into in-center dialysis and home dialysis. The in-center dialysis segment dominated the market in 2023 and is anticipated to reach USD 38.3 billion by the end of forecast period.
 

  • In-center dialysis is widely available across numerous dialysis centers throughout the U.S. These centers are equipped with the necessary facilities and staffed by trained professionals, making it the more accessible and reliable option for the majority of patients, especially those requiring close medical supervision.
     
  • Furthermore, many patients prefer in-center dialysis because it allows for a structured treatment schedule managed by healthcare professionals, reducing the burden of self-care. For those who may not be comfortable with or capable of performing dialysis at home, in-center treatment provides a safer and more convenient alternative.
     
South Atlantic Dialysis Market, 2021- 2032 (USD Billion)

 The South Atlantic dialysis market accounted for USD 6.5 billion market revenue in 2023 and is anticipated to grow at CAGR of 5.1% between 2024 – 2032 period.
 

  • The South Atlantic which includes states like Florida, Georgia, and North and South Carolina, has a rapidly aging population. Florida, in particular, has one of the highest proportions of elderly residents in the country. As age is a major risk factor for chronic kidney disease (CKD) and ESRD, the increasing number of elderly individuals in the region is leading to a higher demand for dialysis services.
     
  • Moreover, the South Atlantic has experienced significant population growth due to domestic migration, with many individuals relocating to the region for its favorable climate and lower cost of living. This population influx has increased the overall demand for healthcare services, including dialysis, as the region accommodates a larger, more diverse population that may include individuals with chronic health conditions requiring dialysis treatment.
     

Northeast dialysis market is projected to grow remarkably in the coming years.
 

  • In response to the growing number of ESRD patients, there has been a significant push by healthcare providers in the Northeast to expand home dialysis programs. The region’s healthcare systems are increasingly promoting peritoneal dialysis and home hemodialysis as viable options, offering more flexibility for patients and contributing to the overall growth of the dialysis market.
     
  • Further, states in the Northeast, such as Massachusetts and New York, have implemented progressive healthcare policies that improve access to dialysis treatment. These initiatives include expanded Medicaid coverage and state-funded programs that support low-income patients, making dialysis services more accessible and driving market growth in the region.
Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

U.S. dialysis industry was valued at USD 28.8 billion in 2023 and is expected to exhibit 5.5% CAGR from 2024 to 2032 attributed to the rising number of end-stage renal diseases (ESRD) patients and increasing incidence of diabetes

The hemodialysis type segment in the market recorded USD 25.4 billion in 2023 as it is the standard treatment for the majority of patients with ESRD, particularly those who may not be candidates for home-based therapies.

South Atlantic U.S. dialysis industry size is anticipated to grow at 5.1% CAGR between 2024 and 2032 led by rapidly aging population in Florida, Georgia, and North and South Carolina

Asahi Kasei Corporation, B. Braun Melsungen AG, Baxter International Inc., Becton, Dickinson and Company, DaVita Inc., Fresenius Medical Care AG & Co., Innovative Renal Care., Medtronic plc, Nikkiso Co., Ltd., Nipro Corporation, Toray Industries Inc., and U.S. Renal Care, Inc.

U.S. Dialysis Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 15
  • Tables & Figures: 397
  • Countries covered: 1
  • Pages: 100
 Download Free Sample